Rubicon Research Ltd
₹1,368.35
▲+0.99%
Open
₹1,345.2
High
₹1,383.95
Low
₹1,331.65
Volume
265.2K
Price chart
Daily close · downsampled 5-year history
2025-10-16 · ₹627.452026-06-18 · ₹1,354
Instrument details
- MB Code
- MBEQU5889
- Type
- stock
- ISIN
- INE506V01022
- BSE
- 544578
- Industry
- Pharmaceuticals & Biotechnology
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 513.92 Cr
- Net profit
- 76.79 Cr
- EPS
- 4.6
- YoY revenue
- +43.49%
Price returns
Historical performance
- 1 day
- -1.05%
- 1 month
- +37.55%
- 3 months
- +72.99%
- 1 year
- +115.79%
- 3 years
- +115.79%
- 5 years
- +115.79%
Technicals
Indicator consensus
Bullish
30
Neutral
9
Bearish
7
RSI 71.51(Bearish)
Company documents
Annual reports, concalls, presentations
Annual reports
2Concall transcripts
6Investor presentations
6Corporate announcements
133Corporate timeline
Price chart events · 1 year
Earnings
2026-02-03
{"actualRevenue":4755290000,"estimateRevenue":4672000000,"revenueSurprise":83290000,"revenueSurprisePercent":1.782748287671233,"actualEPS":4.41,"estimateEPS":3.876,"surprise":0.5340000000000003,"surprisePercent":13.77708978328174}
News
2026-06-02
{"description":"Rubicon Research surged 15% to a 52-week high after strong Q4 FY26 results; revenue rose 44%, PAT more than doubled, and the board recommended a dividend.","url":"https://www.business-standard.com/markets/news/rubicon-research-share-price-jumps-15-to-hit-52-week-high-on-q4-results-dividend-news-126060101206_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2026-06-01
{"description":"Rubicon Research jumped 12.55% after reporting Q4 FY26 net profit doubled to Rs 76.78 crore and revenue rose 43.49% to Rs 513.91 crore.","url":"https://www.business-standard.com/markets/capital-market-news/rubicon-research-spurts-after-reporting-strong-q4-performance-126060100884_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2026-02-04
{"description":"Rubicon Research's stock rose 3.35% to Rs 748.20 following a significant 91.2% year-on-year increase in consolidated net profit to Rs 72.79 crore for Q3 FY26, alongside a 51.73% rise in revenue to Rs 475.52 crore.","url":"https://www.business-standard.com/markets/capital-market-news/rubicon-research-surges-after-q3-pat-jumps-91-yoy-to-rs-73-cr-126020400603_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2026-01-13
{"description":"Investec has initiated coverage on Rubicon Research with a 'buy' rating, projecting a 47% EPS CAGR from FY25 to FY28. The firm highlights Rubicon's strategic focus on specialty generics and nasal therapies, forecasting a significant earnings surge and a target price of Rs 820, indicating over 21% upside.","url":"https://www.ndtvprofit.com/markets/rubicon-research-gearing-up-for-multi-year-earnings-surge-says-investec-initiating-bullish-call-heres-why?src=tl_story","sentiment":"Positive","domain":"NDTV Profit"}
News
2025-10-17
{"description":"Rubicon Research Ltd saw its shares surge nearly 28% during its market debut, indicating strong investor interest. This significant jump reflects positive market sentiment towards the company following its IPO.","url":"https://www.thehindubusinessline.com/markets/rubicon-research-shares-jump-nearly-28-in-market-debut-trade/article70170093.ece","sentiment":"Positive","domain":"Business Line"}
News
2025-10-16
{"description":"Rubicon Research Ltd's IPO lists today, buoyed by a high grey market premium (GMP). The IPO was heavily subscribed, with NIIs at 97.61 times and QIBs at 130.26 times, indicating strong demand and positive sentiment ahead of the debut.","url":"https://www.msn.com/en-in/money/markets/rubicon-research-ipo-listing-date-today-here-s-what-gmp-signals-on-share-debut/ar-AA1Oys79?ocid=BingNewsVerp","sentiment":"Positive","domain":"Mint on MSN"}
News
2025-10-15
{"description":"Rubicon Research Ltd. will debut on October 16, 2025, after an oversubscribed IPO that closed on October 14, with a subscription rate of 103.90 times. The Grey Market Premium (GMP) is Rs 128, suggesting a listing price of Rs 613, a 26.39% premium over Rs 485.","url":"https://www.ndtvprofit.com/ipos/rubicon-research-ipo-listing-date-and-latest-gmp-ahead-of-market-debut-this-week","sentiment":"Positive","domain":"NDTV Profit"}
News
2025-10-14
{"description":"Rubicon Research's IPO allotment status will be released on October 14, 2025, after a 109x subscription. The IPO is valued at Rs. 1,377 crore, with an expected listing date of October 16, 2025, and shares anticipated to list at Rs. 622, indicating a 28% gain.","url":"https://www.goodreturns.in/news/rubicon-research-ipo-allotment-out-today-28-listing-gain-expected-after-109x-subscription-check-gmp-1463411.html","sentiment":"Positive","domain":"Goodreturns"}
News
2025-10-14
{"description":"Rubicon Research's IPO allotment can be checked online via BSE, NSE, or MUFG Intime India. The IPO closed on October 13, 2025, with a 103.90 times subscription rate. Allotment is expected on October 14, with shares credited before listing on October 16.","url":"https://www.zeebiz.com/markets/ipo/news-rubicon-research-ipo-allotment-today-a-step-by-step-guide-on-how-you-can-check-your-allotment-status-online-on-bse-nse-380895","sentiment":"Positive","domain":"Zee Business"}